Stablecoins Boost Treasury Bill Demand, Reflect Dollar Dominance, Citi Says
Stablecoins are playing an increasingly important role in both crypto markets and traditional finance, according to a Friday report by Wall Street giant Citigroup.
As stablecoin usage grows, so does their demand for short-term U.S. Treasuries, although substitution from money market funds may limit the net effect, the report said.
Legislation under consideration in Congress could further entrench this trend by requiring reserves to be held in short-dated government debt, the bank noted.
Citi said the U.S. dollar's dominance in stablecoin issuance reflects its status as the global reserve currency, rather than driving it.
Dollar-backed stablecoins like USDT remain dominant, fueled by their central role in crypto trading and blockchain-based payments, the bank said.
Meanwhile, new players like PayPal (PYPL) and Visa (V) are also experimenting with stablecoin use cases, Citi said.
The potential market is significant, $1.6–$3.7 trillion by 2030, according to Citi, but regulatory constraints such as yield restrictions may cap growth.
Still, stablecoin issuance trends could offer insights into the evolving global monetary order, the report added.Sign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Citi upgrades Fisher & Paykel Healthcare Corporation Limited (FSPKF) to a Hold
Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) received a Hold rating and price target from Citi analyst Mathieu Chevrier today. The company's shares closed last Thursday at $20.70. Confident Investing Starts Here: According to TipRanks, Chevrier is an analyst with an average return of -5.4% and a 40.30% success rate. Chevrier covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per Cochlear , and EBOS Group Limited. In addition to Citi, Fisher & Paykel Healthcare Corporation Limited also received a Hold from UBS's Marcus Curley in a report issued on May 29. However, on May 30, Morgan Stanley upgraded Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF) to a Buy. Based on Fisher & Paykel Healthcare Corporation Limited's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $951.2 million and a net profit of $153.2 million. In comparison, last year the company earned a revenue of $815.8 million and had a net profit of $107.3 million
Business Insider
2 hours ago
- Business Insider
Regeneron price target lowered to $650 from $700 at Citi
Citi analyst Geoff Meacham lowered the firm's price target on Regeneron (REGN) to $650 from $700 and keeps a Buy rating on the shares. The company reported mixed itepekimab Phase 3 COPD results in former smokers, the analyst tells investors in a research note. The firm says that wWhile Aerify-1 met its primary endpoint in both dosing arms, Aerify-2 failed to achieve statistical significance improvement at week 52. While Aerify-1 was positive, the path to approval is unclear, contends Citi. Confident Investing Starts Here:
Yahoo
4 hours ago
- Yahoo
Citi names Bank of America veteran Zhang as new China country head
By Selena Li HONG KONG (Reuters) - Citigroup said on Monday it had appointed Wenjie Zhang as its new country officer and banking head for China, after the exit of its former China head in November. Zhang was also named president and executive director of Citibank China, the company said in a statement. The appointment is subject to regulatory approvals. He will act as the lead Citi representative and as its single, coordinated face in the mainland China market, the company said, leading the team and fostering strong regulatory relationships and risk controls. He will fill the role after former Citi China head Luke Lu left in November for personal reasons. Zhang will join Citi in July and will be based in Shanghai, reporting to Marc Luet, Citi's Head of Japan, Asia North and Australia and Banking, the bank said. A seasoned banker with 30 years of experience in corporate and institutional banking, Zhang was most recently the president of China and Shanghai branch manager for Bank of America China, according to Citi's statement. Prior to that, he was co-head of global banking and executive vice president at HSBC China, after stints at JPMorgan, Citi and Credit Agricole CIB. Citi is cutting up to 200 information technology (IT) contractor roles in China, two people familiar told Reuters last month, as the bank looks to hire its own staff globally for such operations to improve risk management and data governance. Citi, which already has a banking business in China, is in the process of setting up a securities unit in the country.
